This document discusses infection control as it relates to transmissible diseases in the dental environment. It defines standard precautions for treating all body fluids as potentially infectious. Microorganisms in the oral cavity like bacteria from the tongue, dental biofilm, and periodontal pockets can cause cross-contamination between people, from people to objects, and from objects to people. Factors that influence the development of infection include the number and virulence of organisms as well as the immune status of the host. Various pathogens transmissible through the oral cavity are discussed, including tuberculosis, viral hepatitis, HIV, herpes viruses, and human papillomavirus.
The document discusses guidelines for taking and recording a patient's medical and dental history. Key points include:
1) A patient's health history must be updated at each appointment as their health can change over time.
2) Patient health records contain confidential information and must be stored securely and only accessed by authorized personnel.
3) Information from a patient's health history, including medications and medical conditions, should be recorded in permanent ink and signed by the patient to document the history was reviewed.
2 exposure control barriers for patient and cliniciandvernetti
The document discusses various barriers and protocols for protecting patients and clinicians from exposure during clinical care. It covers immunizations, personal protective equipment like masks, gloves and eyewear, hand hygiene protocols, latex sensitivity, and factors to educate patients on for their protection. Guidelines are provided for annual tuberculosis skin tests, influenza vaccines, proper use and disposal of PPE, and handwashing indications. Risk groups for latex allergies include healthcare workers and those with frequent medical procedures or certain food allergies.
This document discusses bloodborne pathogens and the risks they pose. It defines bloodborne pathogens as infectious microorganisms found in blood, including HIV, hepatitis B, and hepatitis C. These pathogens can be transmitted via blood or other bodily fluids through routes like needle sharing, injuries from contaminated sharps, childbirth, and sexual intercourse. The document outlines universal precautions healthcare workers should take like wearing gloves and washing hands to prevent transmission of bloodborne diseases.
Big Tree Volunteer Fire Company's 2013 infectious disease training document provided instructions and objectives for its knowledge assessment on infectious diseases. It covered topics like universal precautions, personal protective equipment, disease transmission, exposure control plans, and relevant laws and regulations. The training was meant to educate firefighters on minimizing disease transmission risks and properly handling potential exposures.
This document provides information and recommendations for preventing occupational exposure to bloodborne pathogens like hepatitis B, hepatitis C, and HIV. It discusses vaccination as the most effective way to prevent hepatitis B infection and outlines post-exposure prophylaxis protocols for different exposure scenarios based on vaccination status and characteristics of the exposure. No vaccine exists for hepatitis C, so the focus is on screening, risk reduction counseling, and adhering to standard precautions. Rapid testing and prompt initiation of antiretroviral therapy within 24 hours of exposure are recommended for occupational exposure to HIV.
Major reason for failures in the field of medicine is infections. So its a prime duty to know and follow the protocols to infection control, in the dental field as well.
Risk of Diseases Transmission During Dental Surgery| Mode of Trasmission of D...Dr. Rajat Sachdeva
Some Possible Diseases Risk are Syphilis, Tuberculosis, AIDS and Hepatitis B, C, Influenza, Measles, Mumps, Rubella and Varicella, which are easily transferred to the Dentists, if safety protocols does not followed by the Dentists.
Standard Precaution, Use of Personal Protection equipment, Proper Disposable of waste material.
The document discusses guidelines for taking and recording a patient's medical and dental history. Key points include:
1) A patient's health history must be updated at each appointment as their health can change over time.
2) Patient health records contain confidential information and must be stored securely and only accessed by authorized personnel.
3) Information from a patient's health history, including medications and medical conditions, should be recorded in permanent ink and signed by the patient to document the history was reviewed.
2 exposure control barriers for patient and cliniciandvernetti
The document discusses various barriers and protocols for protecting patients and clinicians from exposure during clinical care. It covers immunizations, personal protective equipment like masks, gloves and eyewear, hand hygiene protocols, latex sensitivity, and factors to educate patients on for their protection. Guidelines are provided for annual tuberculosis skin tests, influenza vaccines, proper use and disposal of PPE, and handwashing indications. Risk groups for latex allergies include healthcare workers and those with frequent medical procedures or certain food allergies.
This document discusses bloodborne pathogens and the risks they pose. It defines bloodborne pathogens as infectious microorganisms found in blood, including HIV, hepatitis B, and hepatitis C. These pathogens can be transmitted via blood or other bodily fluids through routes like needle sharing, injuries from contaminated sharps, childbirth, and sexual intercourse. The document outlines universal precautions healthcare workers should take like wearing gloves and washing hands to prevent transmission of bloodborne diseases.
Big Tree Volunteer Fire Company's 2013 infectious disease training document provided instructions and objectives for its knowledge assessment on infectious diseases. It covered topics like universal precautions, personal protective equipment, disease transmission, exposure control plans, and relevant laws and regulations. The training was meant to educate firefighters on minimizing disease transmission risks and properly handling potential exposures.
This document provides information and recommendations for preventing occupational exposure to bloodborne pathogens like hepatitis B, hepatitis C, and HIV. It discusses vaccination as the most effective way to prevent hepatitis B infection and outlines post-exposure prophylaxis protocols for different exposure scenarios based on vaccination status and characteristics of the exposure. No vaccine exists for hepatitis C, so the focus is on screening, risk reduction counseling, and adhering to standard precautions. Rapid testing and prompt initiation of antiretroviral therapy within 24 hours of exposure are recommended for occupational exposure to HIV.
Major reason for failures in the field of medicine is infections. So its a prime duty to know and follow the protocols to infection control, in the dental field as well.
Risk of Diseases Transmission During Dental Surgery| Mode of Trasmission of D...Dr. Rajat Sachdeva
Some Possible Diseases Risk are Syphilis, Tuberculosis, AIDS and Hepatitis B, C, Influenza, Measles, Mumps, Rubella and Varicella, which are easily transferred to the Dentists, if safety protocols does not followed by the Dentists.
Standard Precaution, Use of Personal Protection equipment, Proper Disposable of waste material.
Guidelines for dialysis of COVID -19 Patients Ankit Data
The document provides guidelines for dialysis of COVID-19 patients. It outlines general guidance for dialysis units including adequate supplies, signage, educating staff, and strict adherence to universal precautions. It provides guidance for patients undergoing hemodialysis including screening, mask-wearing, hand hygiene and cough etiquette. Guidance is also given for dialysis staff, disinfection practices, and handling patients requiring dialysis for acute kidney injury or with peritoneal dialysis. Personal protective equipment should be worn when dialyzing COVID-19 positive patients.
This document discusses needlestick injuries among healthcare workers and post-exposure prophylaxis. It provides information on the risks of transmitting various bloodborne pathogens like HIV, Hepatitis B, and Hepatitis C via needlestick injuries. It also outlines the determinants of transmission risk and classifications of exposure incidents and infected sources. The document recommends immediate management of exposures, which includes wound cleansing. It provides treatment regimens for post-exposure prophylaxis of HIV, Hepatitis B, and Hepatitis C. It stresses the importance of vaccination against Hepatitis B for healthcare workers and safe injection practices to prevent needlestick injuries.
This document provides information on bloodborne pathogens (BBPs) and OSHA requirements for employees who may be exposed. It defines BBPs as microorganisms carried in blood that can cause human disease, such as HIV, hepatitis B, and hepatitis C. The training covers BBP diseases, potential exposures, required use of personal protective equipment, cleaning and disposal procedures, and post-exposure evaluation. Following proper precautions and protocols is important for the health and safety of all employees.
Blood borne pathogens like hepatitis B and HIV can be transmitted through contact with infected blood and bodily fluids. Proper precautions must be taken like wearing personal protective equipment, thoroughly washing exposed areas, and properly disposing of contaminated waste. The hepatitis B vaccine series is recommended for those with occupational exposure risk. Universal precautions should always be followed to minimize potential exposure to blood borne pathogens.
This document provides an overview of bloodborne pathogen training required by OSHA for employees. It discusses universal precautions like gloves and proper practices that can decrease transmission of pathogens. Bloodborne pathogens are disease-causing organisms found in blood and body fluids that can be spread through contact with infected blood or fluids. Diseases caused by bloodborne pathogens include hepatitis B, hepatitis C, and HIV. The training stresses treating all blood and body fluids as potentially infected and outlines protective measures like proper cleaning procedures, use of gloves, and handwashing to avoid exposure at work.
Medical students with the potential for workplace exposure to bloodborne pathogens (BBP), human blood, or bodily fluids should review this training prior to their preceptorship.
The new coronavirus is officially called SARS-CoV-2, which stands for severe acute respiratory syndrome coronavirus 2. An infection with this virus can lead to coronavirus disease 19 or COVID-19.
SARS-CoV-2 is related to the coronavirus SARS-CoV, which caused another kind of coronavirus disease in 2002 to 2003. However, from what we know so far, SARS-CoV-2 is different from other viruses and including other coronaviruses.
#coronavirus #coronavirusprevention
This document discusses universal precautions and infection control for preventing the spread of communicable diseases. It outlines that all blood and body fluids should be treated as potentially infectious. Proper hand washing, covering cuts, and wearing gloves when handling body fluids can help prevent disease transmission. Common bloodborne pathogens like hepatitis B, hepatitis C, and HIV/AIDS are explained. The document provides information on risk of infection via contaminated needles or mucous membrane exposure. Engineering controls, personal protective equipment, work practice controls, and proper disposal of biohazardous waste are recommended to reduce disease transmission risk. Next steps after an exposure are also covered.
The document provides guidance on COVID-19 including describing the virus, its symptoms and risk factors, how it spreads, steps to prevent spread through proper hand washing, cleaning, social distancing and use of personal protective equipment (PPE) like face masks, gowns and gloves, what to do if someone shows symptoms, and guidelines for caring for COVID-19 patients including donning and doffing PPE safely.
The document discusses Coronaviruses including their genome structure, appearance under electron microscopy, common strains that infect humans such as SARS and MERS, symptoms of COVID-19 including less common symptoms and serious symptoms, methods of transmission, prevention techniques like social distancing, hand hygiene, respiratory hygiene, definitions of suspect/probable infected individuals and types of contacts, and strategies for community-based surveillance.
The document discusses the OSHA bloodborne pathogens standard for schools. It defines bloodborne pathogens as disease-causing microorganisms that may be present in human blood or other potentially infectious materials. The standard is meant to minimize risks of exposure to blood or body fluids and requires training, vaccination, universal precautions, and personal protective equipment. It also provides information about specific bloodborne diseases like HIV and HBV, their transmission, symptoms, and prevention methods.
The document discusses occupational exposure to bloodborne pathogens and OSHA's Bloodborne Pathogens standard. It covers who is covered by the standard, modes of transmission of communicable diseases, universal precautions that must be followed, and required engineering and work practice controls and personal protective equipment to reduce risk of exposure. The standard also mandates training, medical surveillance, hepatitis B vaccinations, and other measures.
1. Leptospirosis is caused by the bacteria Leptospira interrogans, which is transmitted through contact with infected animal urine or tissues. Common symptoms include jaundice, hemorrhage, and acute renal failure. Diagnosis is challenging due to low success of isolation and unreliable direct demonstration. Early antibiotic treatment is important to prevent complications.
2. Pulmonary tuberculosis is caused by the bacteria Mycobacterium tuberculosis, which is spread through airborne droplets from the lungs of infected individuals. Symptoms include hemoptysis and anorexia. Diagnosis involves tuberculin skin testing, chest radiography, and sputum smear/culture. Standard treatment is a multi-drug
This document discusses COVID-19 epidemiology and prevention. It begins with an introduction to coronaviruses and COVID-19. It then covers the origin, transmission, clinical features, epidemiology, prevention, and treatment of COVID-19. It emphasizes the importance of social distancing, hand hygiene, and proper use of masks and PPE to prevent community transmission. It also provides guidance for safe practices in healthcare settings.
Hospital acquired infections are infections that patients acquire during their hospital stay that were not present upon admission. They can arise from various sources including other patients, healthcare workers, contaminated equipment or environment. Common infections include surgical site infections, urinary tract infections and pneumonia. Universal precautions like hand hygiene, use of personal protective equipment, safe handling of sharps and waste and cleaning and disinfection of equipment are important measures to prevent the spread of hospital acquired infections.
Hospital acquired infections (HAIs) are infections caught in the hospital that are potentially caused by antibiotic-resistant organisms. Three main types of precautions are used to prevent the spread of HAIs: standard precautions which include gloves and gowns, contact precautions for direct or indirect contact transmission, and droplet precautions for pathogens spread through coughs or sneezes within 6-10 feet. Innovations to reduce HAIs include scrubs that repel liquids, automated hand hygiene systems, UV disinfecting stations, and rotating CSSD worker shifts every 6 months.
Infection control disease transmission([1]dvernetti
This document discusses infection control and various transmissible diseases that are relevant to dentistry. It covers standard precautions for treating all patients as potentially infectious. Common microorganisms in the oral cavity that can lead to cross-contamination between people and surfaces are described. Specific infectious diseases addressed include tuberculosis, viral hepatitis, HIV/AIDS, herpes viruses, and their transmission routes. Factors influencing the risk of infection and treatment considerations for each disease are summarized.
Hepatitis means inflammation of the liver. The liver is a vital organ that processes nutrients, filters the blood, and fights infections. When the liver is inflamed or damaged, its function can be affected. Heavy alcohol use, toxins, some medications, and certain medical conditions can cause hepatitis.
The role that a dentist can play in prevention of hepatitis is by considering each and every patient as a potential carrier of hepatitis. Proper infection control and sterilization protocols should be followed in order to reduce the risk of infection. Dental surgeons are at a greater risk of exposure than the other specialists in the medical fields because of their exposure to aerosols during ultrasonic scaling. So, they should lay special emphasis on prevention and protection against hepatitis.
Merely celebrating World Hepatitis Day on 28 July is not sufficient for increasing awareness in the community. It is an opportunity for the people and health policy makers globally for more knowledge sharing and finding better approaches for control of HBV and HCV infections in their communities. The role of media in collaboration with gastroenterologists, hepatologists, general and dental surgeons, and infectious centers for generation of massive public informative and educational materials is very critical.
The following are the guidelines for treating hepatitis patients
No dental treatment other than urgent care should be rendered for a patient with acute viral hepatitis[2]
Hepatitis B is of primary concern to the dentist. Individuals still carry the virus up to 3 months after the symptoms have disappeared, so any patient with a recent history of hepatitis B should be treated for dental emergency problems only[6]
For patient with a past history of hepatitis, consult the physician to determine the type of hepatitis, course and length of the disease, mode of transmission, and any chronic liver disease or viral carrier state
For recovered HAV or HEV, perform routine periodontal care
For recovered HBV and HDV, consult with the physician and order HBsAg and HBs laboratory tests.
If HBsAg and anti-HBs tests are negative but HBV is suspected, order another HBs determination
Patients who are HBsAg positive are probably infective (chronic carriers); the degree of infectivity is measured by an HBsAg determination
Patients who are anti-HBs positive may be treated routinely
Patients who are HBsAg negative may be treated routinely..
Work practice controls are an important adjunct for preventing blood exposures. They are as follows:[23]
Using a one-handed scoop technique, a mechanical device designed for holding the needle cap to facilitate one-handed recapping, or an engineered sharp injury protection device (e.g., needles with re-sheathing mechanisms) for recapping needles between uses and before disposal
Not bending or breaking needles before disposal
Avoid passing a syringe with an unsheathed needle.
Bloodborne pathogens like hepatitis B, hepatitis C, and HIV can be transmitted through contact with infected blood or bodily fluids. Workers who are exposed to bloodborne pathogens through injuries from needles, broken glass, or contact with mucous membranes or non-intact skin are at risk of serious infections. Prevention methods include vaccination, use of protective equipment, screening of blood and tissue donors, and modification of high-risk behaviors. Standard precautions should be followed to treat all bodily fluids as potentially infectious and avoid contact with blood or fluids.
Guidelines for dialysis of COVID -19 Patients Ankit Data
The document provides guidelines for dialysis of COVID-19 patients. It outlines general guidance for dialysis units including adequate supplies, signage, educating staff, and strict adherence to universal precautions. It provides guidance for patients undergoing hemodialysis including screening, mask-wearing, hand hygiene and cough etiquette. Guidance is also given for dialysis staff, disinfection practices, and handling patients requiring dialysis for acute kidney injury or with peritoneal dialysis. Personal protective equipment should be worn when dialyzing COVID-19 positive patients.
This document discusses needlestick injuries among healthcare workers and post-exposure prophylaxis. It provides information on the risks of transmitting various bloodborne pathogens like HIV, Hepatitis B, and Hepatitis C via needlestick injuries. It also outlines the determinants of transmission risk and classifications of exposure incidents and infected sources. The document recommends immediate management of exposures, which includes wound cleansing. It provides treatment regimens for post-exposure prophylaxis of HIV, Hepatitis B, and Hepatitis C. It stresses the importance of vaccination against Hepatitis B for healthcare workers and safe injection practices to prevent needlestick injuries.
This document provides information on bloodborne pathogens (BBPs) and OSHA requirements for employees who may be exposed. It defines BBPs as microorganisms carried in blood that can cause human disease, such as HIV, hepatitis B, and hepatitis C. The training covers BBP diseases, potential exposures, required use of personal protective equipment, cleaning and disposal procedures, and post-exposure evaluation. Following proper precautions and protocols is important for the health and safety of all employees.
Blood borne pathogens like hepatitis B and HIV can be transmitted through contact with infected blood and bodily fluids. Proper precautions must be taken like wearing personal protective equipment, thoroughly washing exposed areas, and properly disposing of contaminated waste. The hepatitis B vaccine series is recommended for those with occupational exposure risk. Universal precautions should always be followed to minimize potential exposure to blood borne pathogens.
This document provides an overview of bloodborne pathogen training required by OSHA for employees. It discusses universal precautions like gloves and proper practices that can decrease transmission of pathogens. Bloodborne pathogens are disease-causing organisms found in blood and body fluids that can be spread through contact with infected blood or fluids. Diseases caused by bloodborne pathogens include hepatitis B, hepatitis C, and HIV. The training stresses treating all blood and body fluids as potentially infected and outlines protective measures like proper cleaning procedures, use of gloves, and handwashing to avoid exposure at work.
Medical students with the potential for workplace exposure to bloodborne pathogens (BBP), human blood, or bodily fluids should review this training prior to their preceptorship.
The new coronavirus is officially called SARS-CoV-2, which stands for severe acute respiratory syndrome coronavirus 2. An infection with this virus can lead to coronavirus disease 19 or COVID-19.
SARS-CoV-2 is related to the coronavirus SARS-CoV, which caused another kind of coronavirus disease in 2002 to 2003. However, from what we know so far, SARS-CoV-2 is different from other viruses and including other coronaviruses.
#coronavirus #coronavirusprevention
This document discusses universal precautions and infection control for preventing the spread of communicable diseases. It outlines that all blood and body fluids should be treated as potentially infectious. Proper hand washing, covering cuts, and wearing gloves when handling body fluids can help prevent disease transmission. Common bloodborne pathogens like hepatitis B, hepatitis C, and HIV/AIDS are explained. The document provides information on risk of infection via contaminated needles or mucous membrane exposure. Engineering controls, personal protective equipment, work practice controls, and proper disposal of biohazardous waste are recommended to reduce disease transmission risk. Next steps after an exposure are also covered.
The document provides guidance on COVID-19 including describing the virus, its symptoms and risk factors, how it spreads, steps to prevent spread through proper hand washing, cleaning, social distancing and use of personal protective equipment (PPE) like face masks, gowns and gloves, what to do if someone shows symptoms, and guidelines for caring for COVID-19 patients including donning and doffing PPE safely.
The document discusses Coronaviruses including their genome structure, appearance under electron microscopy, common strains that infect humans such as SARS and MERS, symptoms of COVID-19 including less common symptoms and serious symptoms, methods of transmission, prevention techniques like social distancing, hand hygiene, respiratory hygiene, definitions of suspect/probable infected individuals and types of contacts, and strategies for community-based surveillance.
The document discusses the OSHA bloodborne pathogens standard for schools. It defines bloodborne pathogens as disease-causing microorganisms that may be present in human blood or other potentially infectious materials. The standard is meant to minimize risks of exposure to blood or body fluids and requires training, vaccination, universal precautions, and personal protective equipment. It also provides information about specific bloodborne diseases like HIV and HBV, their transmission, symptoms, and prevention methods.
The document discusses occupational exposure to bloodborne pathogens and OSHA's Bloodborne Pathogens standard. It covers who is covered by the standard, modes of transmission of communicable diseases, universal precautions that must be followed, and required engineering and work practice controls and personal protective equipment to reduce risk of exposure. The standard also mandates training, medical surveillance, hepatitis B vaccinations, and other measures.
1. Leptospirosis is caused by the bacteria Leptospira interrogans, which is transmitted through contact with infected animal urine or tissues. Common symptoms include jaundice, hemorrhage, and acute renal failure. Diagnosis is challenging due to low success of isolation and unreliable direct demonstration. Early antibiotic treatment is important to prevent complications.
2. Pulmonary tuberculosis is caused by the bacteria Mycobacterium tuberculosis, which is spread through airborne droplets from the lungs of infected individuals. Symptoms include hemoptysis and anorexia. Diagnosis involves tuberculin skin testing, chest radiography, and sputum smear/culture. Standard treatment is a multi-drug
This document discusses COVID-19 epidemiology and prevention. It begins with an introduction to coronaviruses and COVID-19. It then covers the origin, transmission, clinical features, epidemiology, prevention, and treatment of COVID-19. It emphasizes the importance of social distancing, hand hygiene, and proper use of masks and PPE to prevent community transmission. It also provides guidance for safe practices in healthcare settings.
Hospital acquired infections are infections that patients acquire during their hospital stay that were not present upon admission. They can arise from various sources including other patients, healthcare workers, contaminated equipment or environment. Common infections include surgical site infections, urinary tract infections and pneumonia. Universal precautions like hand hygiene, use of personal protective equipment, safe handling of sharps and waste and cleaning and disinfection of equipment are important measures to prevent the spread of hospital acquired infections.
Hospital acquired infections (HAIs) are infections caught in the hospital that are potentially caused by antibiotic-resistant organisms. Three main types of precautions are used to prevent the spread of HAIs: standard precautions which include gloves and gowns, contact precautions for direct or indirect contact transmission, and droplet precautions for pathogens spread through coughs or sneezes within 6-10 feet. Innovations to reduce HAIs include scrubs that repel liquids, automated hand hygiene systems, UV disinfecting stations, and rotating CSSD worker shifts every 6 months.
Infection control disease transmission([1]dvernetti
This document discusses infection control and various transmissible diseases that are relevant to dentistry. It covers standard precautions for treating all patients as potentially infectious. Common microorganisms in the oral cavity that can lead to cross-contamination between people and surfaces are described. Specific infectious diseases addressed include tuberculosis, viral hepatitis, HIV/AIDS, herpes viruses, and their transmission routes. Factors influencing the risk of infection and treatment considerations for each disease are summarized.
Hepatitis means inflammation of the liver. The liver is a vital organ that processes nutrients, filters the blood, and fights infections. When the liver is inflamed or damaged, its function can be affected. Heavy alcohol use, toxins, some medications, and certain medical conditions can cause hepatitis.
The role that a dentist can play in prevention of hepatitis is by considering each and every patient as a potential carrier of hepatitis. Proper infection control and sterilization protocols should be followed in order to reduce the risk of infection. Dental surgeons are at a greater risk of exposure than the other specialists in the medical fields because of their exposure to aerosols during ultrasonic scaling. So, they should lay special emphasis on prevention and protection against hepatitis.
Merely celebrating World Hepatitis Day on 28 July is not sufficient for increasing awareness in the community. It is an opportunity for the people and health policy makers globally for more knowledge sharing and finding better approaches for control of HBV and HCV infections in their communities. The role of media in collaboration with gastroenterologists, hepatologists, general and dental surgeons, and infectious centers for generation of massive public informative and educational materials is very critical.
The following are the guidelines for treating hepatitis patients
No dental treatment other than urgent care should be rendered for a patient with acute viral hepatitis[2]
Hepatitis B is of primary concern to the dentist. Individuals still carry the virus up to 3 months after the symptoms have disappeared, so any patient with a recent history of hepatitis B should be treated for dental emergency problems only[6]
For patient with a past history of hepatitis, consult the physician to determine the type of hepatitis, course and length of the disease, mode of transmission, and any chronic liver disease or viral carrier state
For recovered HAV or HEV, perform routine periodontal care
For recovered HBV and HDV, consult with the physician and order HBsAg and HBs laboratory tests.
If HBsAg and anti-HBs tests are negative but HBV is suspected, order another HBs determination
Patients who are HBsAg positive are probably infective (chronic carriers); the degree of infectivity is measured by an HBsAg determination
Patients who are anti-HBs positive may be treated routinely
Patients who are HBsAg negative may be treated routinely..
Work practice controls are an important adjunct for preventing blood exposures. They are as follows:[23]
Using a one-handed scoop technique, a mechanical device designed for holding the needle cap to facilitate one-handed recapping, or an engineered sharp injury protection device (e.g., needles with re-sheathing mechanisms) for recapping needles between uses and before disposal
Not bending or breaking needles before disposal
Avoid passing a syringe with an unsheathed needle.
Bloodborne pathogens like hepatitis B, hepatitis C, and HIV can be transmitted through contact with infected blood or bodily fluids. Workers who are exposed to bloodborne pathogens through injuries from needles, broken glass, or contact with mucous membranes or non-intact skin are at risk of serious infections. Prevention methods include vaccination, use of protective equipment, screening of blood and tissue donors, and modification of high-risk behaviors. Standard precautions should be followed to treat all bodily fluids as potentially infectious and avoid contact with blood or fluids.
A Presentation Presented To orient about HIV, AIDS and STIs for Development of Knowledge, Attitude, and Practice for Prevention of HIV and STIs for College Students.
The document provides an overview of HIV/AIDS including:
1. The history and epidemiology of HIV/AIDS globally and in Egypt. HIV was first identified in 1981 and transmission occurs through unprotected sex, blood transfusions, and mother-to-child. Rates in Egypt have increased in recent years.
2. The life cycle and stages of HIV infection from initial binding to T-cells through replication and progression to AIDS if untreated.
3. Effective prevention methods including antiretroviral treatment for pregnant women, voluntary medical male circumcision, pre-exposure prophylaxis, and consistent condom use which can reduce risk of transmission by over 90%.
Invasion of the skin or mucous membranes by a pathogenic organism or parasite.
Infection in which entrance of the pathogenic organism (or the parasite) occurs through the skin or mucus membranes.
Some infectious agents can invade the intact (undamaged) skin or mucous membranes, but the majority needs injured surfaces in the form of abrasions, scratches, wounds or ulcers.
Epidemiologic characteristics of Hemocontact Infections. Viral hepatitis B. V...Aniuta Sydorchuk
This document discusses hemocontact infections, which are blood-borne infections transmitted via contact with blood or other body fluids. It focuses on viral hepatitis B, viral hepatitis C, and Ebola hemorrhagic fever. For each disease, it covers the etiology, epidemiology, pathogenesis, clinical presentation, diagnosis, treatment and prevention. It compares the key differences between hepatitis B and C, such as transmission routes, incubation periods, likelihood of chronic infection, and serological tests used for diagnosis. For Ebola, it describes the disease progression, symptoms, laboratory diagnostics and supportive care approach, as there are currently no approved vaccines or treatments.
This document discusses several viruses including hepatitis, HIV, COVID-19, and H1N1. It provides information on the structure, transmission, clinical features, diagnosis, and treatment of each virus. Precautions for dental professionals are discussed, including protective equipment, sharp disposal, sterilization of instruments, and handling potential exposures. The document aims to educate on viral infections that are important for dental care providers to understand for infection control.
The document discusses hepatitis A-G viruses and viral hepatitis. It provides details on the transmission, clinical features, diagnosis, and prevention of hepatitis A and B viruses. Hepatitis A virus is transmitted through the fecal-oral route, has an average incubation period of 30 days, and causes an acute infection with no chronic sequelae. Hepatitis B virus can be transmitted through blood, sexual contact and perinatal transmission. It may cause either an acute infection or develop into a chronic infection associated with long-term liver problems. Laboratory tests are used to diagnose both viruses and vaccines are available to prevent infection.
This document provides information on communicable diseases, focusing on HIV/AIDS, hepatitis B, hepatitis C, and hepatitis D. It defines each disease and describes their causes, transmission methods, symptoms, stages of infection, treatment options, and prevention methods. Some key points include:
- HIV damages the immune system, potentially leading to AIDS if untreated. Antiretroviral therapy can control HIV and prolong lives.
- Hepatitis B, C and D are transmitted through contact with infectious bodily fluids and can cause acute or chronic liver infection/disease.
- Prevention strategies include vaccination, safe sex practices, sterile medical equipment, and avoiding needle sharing.
- Testing and treatment are important for controlling diseases and monitoring liver
Prevention and Control of AIDS for World AIDS dayMostafa Mahmoud
The document discusses prevention and control of AIDS, including:
1. HIV can be transmitted through certain body fluids like blood, semen, vaginal secretions, and breast milk. The most common modes of transmission are unprotected sex and sharing needles.
2. Prevention methods include condom use, pre-exposure prophylaxis, treatment of infected mothers, sterile needle programs, and post-exposure prophylaxis for healthcare workers with needlestick injuries.
3. Healthcare workers should follow standard precautions like hand hygiene, personal protective equipment, and safe disposal of needles to prevent transmission between patients and staff. Proper sterilization and cleaning of medical equipment is also important.
This document provides information about HIV/AIDS, including its causes, symptoms, testing, treatment and prevention. It defines HIV as the virus that causes AIDS, with HIV being the infectious stage and AIDS being the late stage disease. Some key points include:
- HIV attacks CD4 cells and progresses from acute infection to asymptomatic infection to AIDS without treatment
- Common symptoms of AIDS include opportunistic infections like PCP, tuberculosis, and cancers like Kaposi's sarcoma
- Screening and confirmatory tests are used to diagnose HIV, and treatment involves antiretroviral drugs as lifelong therapy
- Prevention methods include safe sex practices, needle exchange, blood safety, and antiretroviral treatment of infected
This document summarizes several blood-borne diseases of concern to dentistry, including HIV, hepatitis viruses (HAV, HBV, HCV), herpes simplex viruses 1-3, tuberculosis, and the novel coronavirus. For each disease, it describes the causative agent, signs and symptoms, mode of transmission, and recommended infection control practices in dental settings to prevent transmission. Standard precautions like use of personal protective equipment, sterilization of instruments, and proper handling of sharps are emphasized. Risk of transmission is highest during aerosol-generating procedures, so limitations or precautions during such tasks are advised.
The document discusses several viral infections:
- HIV weakens the immune system and can lead to AIDS. There are two main types of HIV viruses.
- Bird flu, or avian influenza, is caused by influenza A viruses that infect birds and can spread to humans. Common symptoms are similar to regular flu but it can also cause pneumonia.
- Swine flu is caused by H1N1 viruses that originated in pigs but can infect humans. It shares common flu symptoms.
- Nipah virus is transmitted from bats and pigs to humans and has a high mortality rate. Symptoms include fever, cough, and breathing difficulties.
Hepatitis C is a liver disease caused by the hepatitis C virus. It is transmitted through exposure to infected blood, most commonly through sharing needles or other drug use equipment. Only about one-third of people show symptoms during initial infection, which may include fatigue, abdominal pain, and jaundice. Most people go on to develop chronic hepatitis C infection without symptoms for many years. Advanced liver disease from hepatitis C may lead to complications like jaundice, ascites, bleeding, and liver cancer. Co-infection with HIV increases the challenges of diagnosing and treating hepatitis C.
Hepatitis C virus causes hepatitis C, an inflammation of the liver. It is a small enveloped RNA virus that is transmitted through exposure to infectious blood, such as receiving contaminated blood transfusions, injections with unclean needles, or from an infected mother to her baby during childbirth. There is currently no vaccine for hepatitis C, but chronic cases are treated with pegylated interferon and ribavirin medications. New oral protease inhibitor drugs are also being used to treat genotype 1 hepatitis C infections.
The document provides information about common infectious diseases in Malaysia, including definitions, terminology, and details on specific diseases. It discusses AIDS/HIV, hepatitis (types A-E), and dengue. For AIDS/HIV, it describes transmission, signs and symptoms, diagnosis and treatment. For hepatitis, it explains the different types and how they are transmitted. Dengue is described as a mosquito-borne viral disease causing fever and in severe cases, hemorrhagic fever.
HIV/AIDS is a growing concern in Pakistan. While prevalence is currently low, it is a high risk country. HIV attacks the immune system, eventually leading to AIDS if untreated. There is no cure for HIV/AIDS, but treatment can suppress the virus. Common transmission methods include unprotected sex and needle sharing. Prevention focuses on abstinence, monogamy, condoms and clean needles. Symptoms vary from flu-like illness to opportunistic infections as immunity declines. Testing and treatment are important to manage the disease. Research continues on vaccines and treatments to control the HIV/AIDS epidemic.
Similar to Infection control; Transmissible Disease (20)
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
Feeding plate for a newborn with Cleft Palate.pptxSatvikaPrasad
A feeding plate is a prosthetic device used for newborns with a cleft palate to assist in feeding and improve nutrition intake. From a prosthodontic perspective, this plate acts as a barrier between the oral and nasal cavities, facilitating effective sucking and swallowing by providing a more normal anatomical structure. It helps to prevent milk from entering the nasal passage, thereby reducing the risk of aspiration and enhancing the infant's ability to feed efficiently. The feeding plate also aids in the development of the oral muscles and can contribute to better growth and weight gain. Its custom fabrication and proper fitting by a prosthodontist are crucial for ensuring comfort and functionality, as well as for minimizing potential complications. Early intervention with a feeding plate can significantly improve the quality of life for both the infant and the parents.
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyR3 Stem Cell
Dr. David Greene, founder and CEO of R3 Stem Cell, is at the forefront of groundbreaking research in the field of cardiology, focusing on the transformative potential of stem cell therapy. His latest work emphasizes innovative approaches to treating heart disease, aiming to repair damaged heart tissue and improve heart function through the use of advanced stem cell techniques. This research promises not only to enhance the quality of life for patients with chronic heart conditions but also to pave the way for new, more effective treatments. Dr. Greene's work is notable for its focus on safety, efficacy, and the potential to significantly reduce the need for invasive surgeries and long-term medication, positioning stem cell therapy as a key player in the future of cardiac care.
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)blessyjannu21
Neurological system includes brain and spinal cord. It plays an important role in functioning of our body. Encephalitis is the inflammation of the brain. Causes include viral infections, infections from insect bites or an autoimmune reaction that affects the brain. It can be life-threatening or cause long-term complications. Treatment varies, but most people require hospitalization so they can receive intensive treatment, including life support.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
Can Allopathy and Homeopathy Be Used Together in India.pdfDharma Homoeopathy
This article explores the potential for combining allopathy and homeopathy in India, examining the benefits, challenges, and the emerging field of integrative medicine.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
4. Microorganisms of the Oral Cavity
• Infection potential- bacteria come from dorsum of
tongue, dental biofilm, periodontal pockets, caries.
• Cross-contamination occurs:
– Person to person
– Person to inanimate object
– Inanimate object to another person
5. Review
Cross-contamination refers to the spread of microorganisms
from one source to another; this may include which of the
following?
A) Person to person, person to inanimate object, and inanimate
object to person
B) Person to inanimate object only
C) Inanimate object to person only
D) Person to person only
E) Person to inanimate object and inanimate object to person
only
6. Answer
A) Person to person, person to inanimate object, and
inanimate object to person
Person to person, person to inanimate object, and
inanimate object to person are all possible sources of
cross-contamination.
8. Factors Influencing the Development of
Infection
• Number of organisms, duration of exposure
• Virulence of the organism: strength of pathology
• Immune status of host: ability to resist infection
• Host general physical health and nutritional status
9. Factors That Alter Normal Defenses
• Abnormal physical conditions: defective heart valve as
congenital or acquired condition
• Systemic diseases: diabetes mellitus, alcoholism, leukemia,
AIDS
• Drug therapy: Steroids and chemotherapeutic agents
• Prostheses and transplants: joint replacement, cardiac
prosthesis, shunts, organ transplant
10. Air-borne Infection
• Dust-borne organisms
• Aerosol production
– Aerosols: less than 50um in diameter, invisible, suspended
in air for long periods, may contain respiratory disease
organisms
– Spatter: Spatter-heavier, larger particles greater than
50um, air-borne shorter time, may be visible
– Origin: Produced during all intraoral procedures, including
examination and treatment
– Contents: single or clumps of mo adhere to dust or debrie
particles from mouth
11. Prevention of Transmission
• Pre-procedural oral hygiene measures: biofilm removal;
brushing, flossing, mouthrinse
• Interruption of transmission: rubber dam, high evacuation,
manual instrumentation, ventilation, filtration
• Clean water: EPA standards. Run water lines 2 minutes before
and after patient in clinic
• Protection of the clinician: PPE’s
12. Pathogens Transmissible by the Oral Cavity
• Tuberculosis
• Viral hepatitis
• AIDS
• Herpetic infections
• Table 2-1 p 28
13. Active TB Infection
Active: incubation as long as 10 weeks
• Usually has a skin or blood test result indicating TB infection
• May have an abnormal chest x-ray or positive sputum smear
• Has active TB bacteria in body
• Usually feels sick with coughing, fever, and weight loss
• May spread TB to others
• Needs treatment to treat active disease
14. Latent TB Infection
Latent:
• Usually has a skin or blood test result indicating TB
infection
• Has a normal chest x-ray or negative sputum smear
• Has inactive TB bacteria body
• Does not feel sick, cannot spread to others
• May need treatment for latent TB infection to
prevent active TB disease
15. How is Active TB Spread?
• Most communicability just before diagnoses
• Spread by inhalation, inoculation and mucous
16. Who is at risk for Active TB?
• Born in country with high TB burden (Asia, India,
Latin America, Soviet Union)
• Child of parents born in country with endemic TB
• Close contact to person with active TB
• Living and working in congested settings (shelters,
long term care)
• Medically underserved (low income, uninsured, drug
abuse)
17. HIV and TB
• HIV testing is recommended for all TB suspects or
confirmed cases
• HIV + persons with TB disease have higher HIV viral
loads that HIV + persons without TB disease
• HIV disease can mask TB symptoms and vice versa
• HIV + person who are skin test+ have an increased
annual risk of TB disease
18. Active TB Treatment
Standard Drug Regimen; RIPE taken for several months
• Rifampin
• Isoniazid
• Pyrazinamide
• Ethambutol
Is a drug resistant illness
21. Hepatitis A(HAV)
• Jaundice, influenza type symptoms, not a chronic infection
• Water and food borne, poor food handling, unwashed hand,
fecal/oral route. Best defense is handwashing
• No carrier state . May treat in clinic. May use the ultrasonic
scaler.
• Traveling to at risk areas, homosexual men, iv drug uses,
hemophiliacs, liver disease
• Immunization available
22. Hepatitis B (HBV)
• Very serious, prolonged illness, liver cancer, significantly
increased occupational hazard of healthcare workers
• 5-10% carrier state. Virus remains in blood and can be found
in blood products during prophylaxis, body fluids and saliva.
Do not treat patients with active Hepatitis B.
• Needlesticks , sexual and perinatal exposure, blood
transfusion occupation, lifestyle, drug abuse
• Immunization available
23. Hepatitis C (HCV)
• Flu-like symptoms. 50-80% chronic carries, 70% liver disease .
Most reason for liver transplants.
• Do not use ultrasonic scaler with previous history.
• Male, alcoholism, HIV or HBV, blood transfusion before 1991,
IV drug abuse, tattooing, piercing, organ transplantation
• No Immunization. Behavior modification, infection control
24. Hepatitis D(HDV)
• Signs and symptoms resemble HBV. Patients with
Hepatitis D also have Hepatitis B
• Do not use ultrasonic scaler with previous history
• Immunization with HBV vaccine also protects the
recipient from delta hepatitis infection.
25. Hepatitis E
• HEV formerly known as enterically transmitted non-A, non-B
hepatitis. Water-borne epidemics.
• No carrier state. May use ultrasonic scaler. Patient fully
recovers and does not carry the virus in the bloodstream.
• Transmitted by contaminated water, person to person, and
fecal oral route.
• No Immunization: sanitary disposal of wastes; handwashing,
especially before handling food.
26. Tips for Remembering Types of Hepatitis
• Consonants refer to the blood-born strains B, C, D
• Vowels refer to fecal-oral transmission A, E
27. Herpes Virus Diseases
• Highly contagious, eight are known to infect
humans.
• Relation to periodontal infections:
opportunistic periodontal pathogens can
occur, making periodontal disease symptoms
more severe.
29. Types of Herpes Infection
• Herpetic whitlow: infection of fingers contacted via skin abrasions from
lesion
• Ocular herpes: HSV 1 or HSV 2 infection of eye
• Herpes simplex type 1 (HSV-1): Oral herpes. HSV 1 and HSV 2 cannot be
distinguished clinically
• Herpes simplex type 2 (HSV-2): Genital herpes. Antiviral therapy can
suppress lesion, but latency can never be erased. Most common STD
• Postpone appointment for active lesions. Acyclovir, an antiviral drug of
choice for treatment for HSV2
30. Types of Herpes Infection
Varicella-herpes zoster virus (HZV):
• Chickenpox: Varicella; highly contagious, acute infection
• Shingles: Herpes zoster; lantent in dorsal root ganglia. Unilateral
eruptions, may occur intraoral
Epstein-Barr virus EBV:
• Infectious mononucleosis: flu-like symptoms, transmitted by saliva or
droplets, last carrier state
• Hairy leukoplakia: associated with AIDS, white, lesion on lateral borders of
tongue
31. Types of Herpes Infections
• Cytomegalovirus (HCMV HHV-5): Adult infection; immunodeficient or
immunosuppressed patients
• Herpes lymphotrophic virus (HHV-6): Childhood infection (6 months to 2
years), roseola infantum, with accompanying high temperature and rash
• Human herpes virus-7 (HHV-7): prevalent in general population, detected
in both healthy gingiva and diseased periodontal tissues.
• Kaposi sarcoma-related virus (KSRV)(HHV-8): immunocompromised
host, a major cofactor in production of Kaposi sarcoma, an AIDS-defining
lesion.
32.
33. Human Papilloma Virus (HPV)
• Over 100 types of HPV
• 40 types infect the genitals, throat, and mouth
• Types 16 and 18 are the cause of 70% of cervical
cancers
• 90 % of genital warts cases are caused by 6 and 11
• HPV testing is available for women undergoing
cervical cancer screening
34. HIV Infection
• Slow, progressive, lethal pandemic caused by infection with the human
immunodeficiency virus.
• Found in most body fluids; transmitted via blood, semen, vaginal
secretions, and breast milk.
• Obtain permission to treat from physician. Do not use the ultrasonic
scaler. Legally need to treat patient
• Unprotected sexual contact with infected person, IV drug users (sharing
needles), transplantation of organs and tissues, occupational exposure,
perinatal transmission, hemophiliacs
35. Methicillin-Resistant Staphylococcus Aureus
• MRSA is a common infection that is resistant to many
antibiotic therapies.
• Endemic in hospitals and institutions.
• It is associated with acute osteomyelitis, bacteremia,
septicemia, cellulitis, conjunctivitis, pneumonia, and toxic
shock syndrome.
• Infection is spread by direct and indirect contact by skin
scales, fomites, equipment, and the environment.
• Incubation period is 4-10 days
36. When HIV becomes AIDS
• http://www.youtube.com/watch?v=68I7JlVhuhY
Editor's Notes
In utero, the oral cavity is sterile.
After birth, within a few hours, a simple oral flora develops.
Microorganisms are transmitted to the infant from mother and other family members or caretakers.
As infant grows, there is continuing introduction of microorganisms. Normal adult microbiota is very complex.
Many salivary bacteria come from dorsum of tongue. Some bacteria are from mucous membranes and gingival/periodontal tissues.
Infectious agent: the invading organism; each organism has its own specific reaction in an infected host.
Reservoir: where invading organisms live and multiply.
Port of exit: mode of escape from the reservoir; organisms exit through body systems such as the respiratory tract, or though skin lesions. Escape from bloodstream may be through skin abrasions, hypodermic needles, or dental instruments.
Mode of transmission: direct, person to person; or indirect by way of intermediate vehicle such as contaminated hands or instrument. Transmission by droplet may be direct from respiratory tract of one person to oral cavity of receiving host. Droplets may also pass indirectly to hands or inanimate objects to be transferred indirectly to susceptible host.
Port of entry of infectious agent into new host. Modes of entry may be similar to modes of exit.
Susceptible host: does not have immunity to the invading infectious agent.
Patient’s complete medical/dental history is reviewed, specific problems are identified, and necessary precautions or modifications to care noted.
Abnormal conditions: defective heart valve as congenital or acquired condition. Valve defect leaves individual susceptible to infectious endocarditis resulting from dental/dental hygiene invasive procedures.
Systemic diseases: diabetes mellitus, alcoholism, leukemia, , AIDS, and other instances of immunosuppression increase susceptibility to infection.
Drug therapy: agents used in treatment of systemic diseases alter body’s defenses. Steroids and chemotherapeutic agents are immunosuppressive. Prophylactic antibiotics may be indicated to prevent infection.
Prostheses and transplants: joint replacement, cardiac prosthesis, shunts for hydrocephalus, or an organ transplant may require antibiotic premedication for invasive dental procedures.
Dust-bacteria may travel in dust from outside into and within the dental environment
Aerosols-classified by particle size, less than 50um in diameter, invisible, suspended in air for long periods, may contain respiratory disease organisms
Spatter-heaviers, larger particles greater than 50um, air-borne shorter time, may be visible
Origin-created during breathing, speaking, coughing, sneezing. Dental; scaling, air/water spray, polishing, ultrasonic
Content; single or clumps of mo adhere to dust or debrie particles from mouth
Preprocedural: biofilm removal (toothbrushing, flossing) and using antiseptic mouthrinse to reduce numbers of bacteria in aerosols.
Interruption: use of rubber dam, high-volume evacuation, and manual instrumentation as much as possible. Install air control methods to supply adequate ventilation, filtration, and relative humidity. Employ vacuum-cleaning methods (with filter to trap organisms after their suctioned) rather than dust-arousing housekeeping methods.
Clean water: use water that meets EPA regulatory standards for drinking water (less than 500 CFU/mL of heterotrophic water bacteria). Run water through dental equipment lines (handpieces, ultrasonic scalers, air/water syringes) at least 2 minutes at the start of the day and at least 20 to 30 seconds after each patient during the day.
Clinician’s protection: use of mask, shields, and protective eyewear can prevent direct contact of spatter and aerosols with faces of DHCP.
Patient protection: use of protective eyewear can prevent direct spatter and aerosols to the face and eyes of the patient.
TB
HEP A, B, C,D
HIV
Herpes type 1, 2, Zoster
Tuberculosis: special consideration when sterilization and disinfection methods are selected and administered. Incidence of TB has increased in population groups with high prevalence of HIV, and is an AIDS-defining illness. Transmission is by inhalation of fresh droplets containing tubercle bacilli disseminated from sputum and saliva of infected individual by coughing, sneezing, or breathing heavily. Aerosols created in the dental environment during procedures can carry the bacilli as well. Degree to which infected individual produces infectious droplets depends on amount and duration of exposure and susceptibility of the recipient. Maximum communicability is just before the disease is diagnosed.
Incubation period may be as long as 10 weeks. Early symptoms include low-grade fever, loss of appetite, weight loss, and tiring easily. There may be a slight cough and eventually sputum, indicating presence of tubercle bacilli in throat and saliva. Later symptoms show definite temperature elevation, night sweats, weakness, and a persistent cough. Diagnosis is by chest radiograph and tuberculin testing.
Reactive TB focus of an infection may remain inactive and later produce a recurrence. Primary treatment may have been incomplete. Reactivity may be related to a debilitating condition or immunosuppression.
Multidrug-resistant TB: if meds not prescribed or taken properly, the tubercle bacilli can become resistant. Usual course of drug therapy is daily/weekly meds taken for at least 6 months to treat active TB. Principal drugs (or in combination) are isoniazid, pyrazinamide, rifampin, and ethambutol. First line of prevention for multidrug-resistant TB is early diagnosis followed by directly observed therapy (DOT). Second approach is to locate and treat persons with latent TB, particularly those at high risk of reactivation.
Extensively drug-resistant (XDR) TB: multidrug-resistant strains are resistant to at least isoniazid and rifampin, and requires use of second-line drugs for treatment. Reports reveal case of XDR TB emerging that were resistant to all second-line drugs. Cases of XDR are noted to be especially severe in immunosuppressed patients infected with HIV.
Clinical management: official CDC recommendations: periodic risk assessment, taking and updating medical history reviews, including questioning of history of TB and symptoms suggestive of the disease; referral of patients with suggestive TB history or symptoms for medical evaluation; deferral of elective dental treatment (Table 2-2 in text provides guide to patient management); urgent dental care be provided in a facility that can offer isolation, optimal ventilation, and use of highest filtration-level mask for respiratory protection. DHCPs should present for prompt medical evaluation if they have a persistent cough, combined with weight loss, fever, and other symptoms. A separate reception area for suspected or confirmed TB patients is preferred, and appointment scheduling should be arranged to prevent a waiting period.
Clinical findings include lymphadenopathy, and oral lesions, although relatively rare, can be in the form of ulcers on the soft/hard palate or tongue. Within a few weeks of beginning the drug therapies, bacilli in the sputum, cough, and infectivity are decreased.
Droplet nuclei. Many potentially pathogenic microorganisms are disseminated by aerosols and spatter. The primary mode of transmission of tubercle bacilli is by droplet nuclei breathed directly into the lung. But can also be transmitted by inoculation and contact with mucous membranes
New viruses designated non-acde and hep g have emerged in post transfusion patients or injection drug users
General Facts: most common strain worldwide. Occurs more frequently in children and young adults
Transmission: fecal/oral, unsanitary conditions, unwashed hands. Hygiene critical
Process: water and food borne, poor food handling,
blood-borne:early days of infection
Incubation; 15-45 days, 2-3 weeks before jaundice infection is communicable, after, it dimishes. No carrier.
HBV incidence increased significantly during past 20 years; is a serious occupational hazard for healthcare personnel (HCP). Use of strict sterilization of equipment and materials, aseptic techniques, and self-protection for HCP is MANDATORY. HBV occurs at any age and differs from HAV in mode of transmission, length of incubation period, onset, and existence of chronic carrier state.
Transmission: by percutaneous and permucosal exposure; needlestick or sharps injury; intravenous, intramuscular, subcutaneous injury; perinatal exposure; exchange of contaminated needles, syringes, or other intravenous drug user paraphernalia; sexual exposure; infection from blood transfusion and blood products.
Perinatal transmission: during fetal stage, at birth. Infected infant at high risk for chronic infection, which can lead to chronic liver disease or cancer later in life. Preventive measures for pregnant women to be tested for HBsAg and HBeAg.
Individuals at risk or with risk behaviors: factors including occupation, place of residence, lifestyle, confinement to an institution, other diseases and their treatments, and parenteral drug abuse. HCP who adhere to standard precautions with use of protective barriers (gloves, masks, eyewear), who follow essential precautions for blood and other potentially infectious materials, and who have immunity following vaccination or acquired antibody to HBV are at low risk.
Disease process: incubation ranges from 2 to 6 months, with an average of 60 to 90 days. HBsAg may be detected in blood as early as 30 days after exposure to the virus. Presence of serum HBsAg indicates communicability.
Transient subclinical infection: majority of patients do not have icteric stage, but do have subclinical disease; many individuals remain undiagnosed but develop antibodies and permanent immunity. Individual has rapid, strong immune response to HBV and virus is cleared before it can become established.
Acute type B hepatitis: cannot be distinguished from other viral hepatitis infections on basis of clinical signs and symptoms. Preicteric stage (onset) with fever, malaise, and influenza-like symptoms typical of all types of hepatitis. Onset may be slower and more insidious, including skin rash, itching, and joint pain. Convalescence begins with disappearance of jaundice. During this period, antibody increases except in those who become permanent carriers.
Carrier state: chronic carrier is defined as individual with the HBsAg marker in the blood serum for more than 6 months. Many carriers eventually develop cirrhosis or cancer of the liver. Death from chronic liver disease occurs in 15% to 20% of persons infected.
Immunity: presence of HBV antibodies in the serum show previous exposure to HBV, and is therefore immune to reinfection. Pretesting for anit-HBs prior to vaccination for HBV may be indicated.
Prevention: critical occupational hazard for DHCP due to close association with potentially infected body fluids of patients. Every HCP needs to be immunized to minimize possibility of disease acquisition and transmission.
Postexposure prophylaxis (PEP): indications for newborns of HBsAg-positive mothers; exposure to HBsAg-positive blood. High-titer anti-HBs immune globulin (HBIG) is available for PEP.
Associated with blood transfusion and the use of contaminated needles. Now recognized as the MOST common chronic blood-borne infection in the U.S., and most frequent indication for liver transplantation.
Serologic test for antibody to HCV has been developed, and is an established test for blood donors.
Transmission: can be acquired by percutaneous exposure to contaminated blood and plasma derivatives, contaminated needles and syringes, transfusion, or accidental needlestick. HCV has been demonstrated in saliva. Nonpercutaneous routes include sexual transmission and perinatal exposure.
Disease process: onset of HCV can have no clinical symptoms, or patient can have abdominal discomfort, nausea, and vomiting and can progress to jaundice. After acute infection, 50% to 80% will become chronically infected (carriers) and more than 70% will develop serious liver disease. The course of chronic liver disease may progress without symptoms for the first 20 years after infection. First diagnosis may be during blood donor screening or detection of elevated liver enzymes during routine physical examination.
Risk factors: age greater than 40 years at infection, males, moderate to heavy alcohol intake, and coinfection with HIV or HBV. Principle risk factors for HCV include blood transfusion (before 1991), injection drug use, intranasal cocaine use, tattooing, ear/body piercing, perinatal transmission, sexual transmission, hemodialysis, and organ transplantation.
Prevention and control: since no vaccine is available for HCV, behavior modification is essential, including STRICT ATTENTION to infection control procedures for all HCP. Measures recommended for HBV can be applied to HCV.
Delta hepatitis virus, also called the delta agent, causes infection ONLY in the presence of HBV infection.
Diagram shows the delta antigen surrounded by HBsAg.
Transmission: most frequently, delta infection is superimposed on HBsAg carriers. Occurs primarily in individuals with multiple exposures to HBV, especially those with hemophilia and intravenous drug use. Transmission similar to that of HBV, by direct exposure to contaminated blood and serous body fluids, contaminated needles and syringes, sexual contacts, and perinatal transfer.
Disease process: more severe with a greater mortality rate than with HBV alone. Onset is abrupt; signs and symptoms resemble HBV.
Infection can occur in following ways: Coinfection: acute delta hepatitis occurring with acute HBV infection may lead to resolution of both types. Clearance of HBV may lead to clearance of delta virus. Superinfection: acute delta type superimposed on an existing carrier HBV state. HBV carrier state remains unchanged and delta carrier state may develop in addition. Superimposition: chronic delta hepatitis superimposed on chronic HBsAg carrier.
Prevention: all measures used to prevent HBV prevent HDV since delta is dependent on presence of HBV. Immunization with HBV vaccine also protects the recipient from delta hepatitis infection.
HEV formerly known as enterically transmitted non-A, non-B hepatitis. Clinical course and distribution similar to HAV. Associated with water-borne epidemics.
Transmission: HEV transmitted by contaminated water, as well as person-to-person by fecal-oral route. Reported large outbreaks associated with fecally contaminated water sources after heavy rains where sewage disposal was inadequate. Adults affected more than children. Mortality rate in pregnant women has been high.
Prevention and control: sanitary disposal of wastes; handwashing, especially before handling food.
Application in dental setting: strict infection control and daily cleansing of unit water lines.
Herpes virus infections represent wide variety of disease entities that are highly contagious and antigenically distinct. Of know herpes strains, only eight are known to infect humans. These eight have significance for oral health care.
Herpes viruses produce diseases with latent, recurrent, and sometimes malignant tendencies. HS type 2 has been implicated in cervical cancer, and HS type 1 in oral cancer. After infection, the virus has the ability to remain latent in the individual and only become reactivated to produce recurrent infection after certain stimuli or when the body’s immune response is significantly lowered. Immunosuppressed patients have more frequent and severe herpes infections. Herpes viruses are among opportunistic organisms in AIDS.
Relation to periodontal infections: human herpes viruses occur in periodontitis, found in pocket flora with relatively high prevalence. Infection with herpes viruses can suppress a patient’s immunity, and as a result, subgingival overgrowth of opportunistic periodontal pathogens can occur, making periodontal disease symptoms more severe.
HSV-1: primary infection usually occurs in children, but may occur at any age. Antibodies (anti-HSV) are produced, but do not guarantee immunity to recurrent herpes or other herpes virus infections. Sulcular epithelium can serve as reservoir for the viruses. Anti-HSV is present in gingival sulcus fluid. The possibility exists that trauma to oral tissues during dental or DH appointment may bring about herpetic recurrence.
Primary herpetic gingivostomatitis: primary infection with HSV-1 may be mild and isolated to marginal and attached gingiva. Full-blown case presents with widespread oral ulcers that may involve pharyngeal areas. When clinical disease is evident, gingivostomatitis and pharyngitis are most frequent manifestations, with fever, malaise, inability to eat, and 2- to 7-day course of lymphadenopathy. Painful oral vesicular lesions may occur on gingiva, mucosa, tongue, and lips. Patient may be subclinical carrier, and reactivation from trigeminal ganglia may be followed by asymptomatic excretion of viruses in the saliva. Reactivation may also lead to herpetic ulcerations of the lip, the typical “cold sore.”
Herpes labialis (cold sore, fever blister): both HSV-1 and HSV-2 cause genital and oral-facial infections that cannot be distinguished clinically. Reactivation of oral-facial HSV-1 infections are more frequent than oral-facial HSV-2. Recurrent HSV lesions are usually triggered by stress, sunlight, illness, or trauma. Emotional stress and oral trauma of a patient’s dental appointment may well trigger the reactivation.
Prodrome: before the local lesion appears, a forewarning (prodrome) manifested as burning or slight stinging sensations with slight swelling may appear. The recurrent lesion most frequently appears at the vermilion border of the lower lip, but can occur intraorally on the gingiva or hard palate.
Clinical characteristics: a group of vesicles form and eventually ruptures and coalesces. Crusting follows and healing may take up to 10 days. The lesions are infectious, with viral shedding. Care must be taken by the patient because autoinfection (to eye, nose, or genitals) is possible, as is infection of other people
Latent infection of herpes simplex virus. Path of the virus traced from point of viral penetration on lip to establishment of latent infection in the trigeminal ganglion. Triggered by UV light, stress and trama
Whitlow: HSV-1 infection of the fingers that results from viral entry through minor skin abrasions, most frequently found around a fingernail. Transmission occurs from direct contact with vesicular lesion on patient’s lip or with saliva containing viruses. Autoinfection from lip or intraoral herpetic lesion possible while nail biting. Prevention is with use of protective gloves during dental procedures. With standard precautions for infection control, whitlow has become nearly extinct.
Ocular herpes: can be primary or recurrent infection in the eye from HSV-1 or HSV-2. Transmission from splashing saliva or fluid from a vesicular lesion directly into an UNPROTECTED eye. It can also be extension of a facial lesion or infection of infant’s eye in utero or during birth. Symptoms include fever, pain, blurring of vision, swelling, excess tears, and secondary bacterial infection. Herpetic keratoconjunctivitis can cause deep inflammation and when left untreated is a leading cause of loss of sight. Prevention: with standard precautions and use of proper personal protection including eye covering for both clinician and patient, ocular herpetic infection can be prevented.
HSV-2: commonly known as genital herpes, but also occurs as an oral and perioral infection. Antiviral therapy can suppress HSV-2 lesions, but the latency of the virus can never be eradicated.
Clinical management: patient history should question the experience with herpes viruses. Use patient-friendly terms such as “cold sore” or “fever blister.”
POSTPONE appointment for patient with active lesion. Explain problems of transmission to patient: contagiousness, with possible transmission to other patients; autoinoculation possible from instrumentation that can splash viruses to patient’s eye or extend lesion to the nose. Irritation to the lesion(s) can prolong the course and increase severity of the infection. Prodromal state may be most contagious. Patient is requested to call ahead to change scheduled appointment when it is known that lesion is developing.
Treatment: acyclovir, an antiviral drug, has be used in topical, oral, and intravenous forms. It is a selective inhibitor of replication of HSV and is established as the drug of choice for treatment of wide range of herpes virus infections.
Chickenpox (varicella) and shingles (herpes zoster) are caused by the same virus (varicella-zoster virus-VZV).
Chickenpox transmission: highly contagious, may be transmitted by direct contact, droplet (possibly air-borne), or indirect contact with articles soiled by discharge from vesicles and the respiratory tract.
Disease process: primarily disease of children, occasionally found in adults not previously exposed. Can be life threatening in children who are immunocompromised (such as those with HIV infection). When primary maternal VZV occurs during pregnancy, fetal infection may result in congenital malformations. Disease is characterized by maculopapular rash that becomes vesicular in a few days, then scabs. Oral lesions may spread to upper respiratory tract. If the itchy, crusty lesions of the skin are scratched, a secondary bacterial infection may occur.
Shingles: chickenpox leaves lasting immunity, but the VZV remains latent in the dorsal root ganglia. Reactivation in adulthood may result from immunosuppression (such as drug therapy or HIV infection) and in people with advanced neoplastic disease. Shingles consists of localized UNILATERAL eruptions associated with the nerve endings of the area innervated by the infected sensory nerves. When the second division of the trigeminal nerve is involved, intraoral lesions may occur.
EBV: Infectious mononucleosis: generally a disease of adolescents and young adults. Characterized by fever, lymphadenopathy, and sore throat. It is identified by specific atypical lymphocytes called mononucleosis cells. Disease is transmitted orally by direct contact with saliva and by droplet. Viruses are excreted through saliva even when patient is asymptomatic, so there may be long period of communicability or lasting carrier state.
Hairy leukoplakia: EBV replicates within epithelial cells, the lesion associated with subsequent development of AIDS. Tongue lesions appear as white linear lesions along the lateral borders.
HCMV infections are widespread, appear in various forms, with the most severe form developing in infants affected in utero.
Transmission and disease effects: virus from mother’s primary or recurrent infection may affect infant in utero, in the birth canal, or through breast milk. CMV in the fetus can lead to premature birth, anemia, mental retardation, microcephaly, motor disabilities, deafness, and chronic liver disease. The virus is excreted in urine, saliva, cervical secretions, and semen. Infection can result from blood transfusion, posttransplant infection, sexual transmission, respiratory droplet (especially among children—children attending daycare centers have a high prevalence of HCMV). Adult infection: symptomatic infection is relatively rare, but infectious “mono” pneumonitis and other infections may be caused by the virus. HCMV, an opportunistic agent, is common cause of both primary and reactivated infections in immunodeficient or immunosuppressed patients, and is a complication of AIDS. Adults also are affected in periapical pathosis with EBV.
Prevention: handwashing, personal hygiene, and standard precautions for infection control by HCP. Seropositivity of organ donor assessed before transplant.
HLV: widespread distribution among humans; high percentage of population has antibodies. Childhood infection (6 months to 2 years), roseola infantum, with accompanying high temperature and rash. Acts to depress immune system, depletes CD4 lymphocytes, can be cofactor in HIV-AIDS progression. After primary infection, virus persists in latent form. Reactivation can occur after bone marrow transplantation and solid organ transplants, complicated by rejection of the transplant.
HHV-7: prevalent in general population, reactivation of latent infection common in the immunocompromised person. Infection may occur following bone marrow and solid organ transplantation. Periodontal connection: gingival tissue may serve as reservoir for HHV-7; high prevalence of HHV-7 detected in both healthy gingiva and diseased periodontal tissues.
Kaposi sarcoma-related virus: in immunocompromised host, a major cofactor in production of Kaposi sarcoma, an AIDS-defining lesion.
Table 4-3
AIDS is severe pandemic disease caused by infection with the human immunodeficiency virus (HIV-1). HIV-2, isolated in West Africa, and later Europe and North America, has been shown to have similar characteristics and transmission as the original HIV-1. Both are slow, progressive, and often lethal; they have the ability to persist within cells such as macrophages for long periods of time.
HIV-1 infected patients may present with symptoms that range from mild abnormalities in immune response with apparent signs to profound immunosuppression association with life-threatening infections and rare malignant conditions. (Terminology related to HIV-1 and AIDS is found in the text, Box 2-2.)
Transmission: HIV-1 found in most body fluids; transmission demonstrated via blood, semen, vaginal secretions, and breast milk. Virus has also been found in saliva, tears, urine, and bronchial secretions, but transmission by contact with these fluids has not been described.
Sexual contact: virus from infected individual’s blood, semen, or vaginal secretions enters blood circulation through tiny breaks in the rectum, vagina, or penis.
Blood and blood products: injection drug users by contaminated shared needles carrying the virus; transfusion of infected blood. Serologic testing of all donor blood has nearly eliminated this threat of transmission. Transplantation of HIV-infected organs and tissues. Occupational accidental exposure injuries. Perinatal virus transmission across the placenta, or during delivery through exposure within the infected genital tract. Postnatal through breast milk.
Individuals at high risk of infection: sexually active homosexual and bisexual men having multiple partners without practicing safe sex; users or former users of intravenous drugs, especially when contaminated needles are shared; recipients of blood transfusions or blood products prior to mandatory testing for HIV-1 antibodies in 1985; hemophiliacs and other coagulation disorder patients; male and female prostitutes who do not practice safe sex; HCP who do not adhere to strict barrier procedures and do not follow essential blood-borne precautions; females artificially inseminated with HIV-1-infected semen; recipients of HIV-1-infected organ transplants; steady sexual partners of those previously listed who do not practice safe sex; steady sexual partners of those infected with AIDS or at high risk of AIDS who do not practice safe sex; infants born to HIV-1-infected mothers; infants fed breast milk from HIV-1-infected mothers.